1-2 of 2
Anne S. Renteria
Close
Sort by
Journal Articles

Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Clinical Trials & Observations
Yi-Bin Chen, Nirav N. Shah, Anne S. Renteria, Corey Cutler, Johan Jansson, Mona Akbari, Chunlin Chen, Syed Quadri, Andrejus Parfionovas, Steven M. Devine
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4136–4146.
https://doi.org/10.1182/bloodadvances.2019000893
Published: 2019
Includes: Supplemental data
Journal Articles

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802

Clinical Trials & Observations
Shernan G. Holtan, Todd E. DeFor, Angela Panoskaltsis-Mortari, Nandita Khera, John E. Levine, Mary E. D. Flowers, Stephanie J. Lee, Yoshihiro Inamoto, George L. Chen, Sebastian Mayer, Mukta Arora, Jeanne Palmer, Corey S. Cutler, Sally Arai, Aleksandr Lazaryan, Laura F. Newell, Madan H. Jagasia, Iskra Pusic, William A. Wood, Anne S. Renteria, Gregory Yanik, William J. Hogan, Elizabeth Hexner, Francis Ayuk, Ernst Holler, Udomsak Bunworasate, Yvonne A. Efebera, James L. M. Ferrara, Joseph Pidala, Alan Howard, Juan Wu, Javier Bolaños-Meade, Vincent Ho, Amin Alousi, Bruce R. Blazar, Daniel J. Weisdorf, Margaret L. MacMillan
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1882–1888.
https://doi.org/10.1182/bloodadvances.2018017343
Published: 2018
Includes: Supplemental data